Skip to main content

Table 1 Participant Baseline Demographic and Clinical Characteristics

From: Symptom-burden in people living with frailty and chronic kidney disease

 

Non-Frail (n = 128)

Frail (n = 225)

Unadjusted

P Value

Age (years), mean (SE)

71.5 (0.9)

77.7 (0.6)

< 0.001*

Female, n (%)

70 (55)

130 (58)

 

Current or ex-smoker, n (%)

57 (45)

125 (56)

 

University/college qualification, n (%)

43 (34)

57 (25)

 

Self-reported health problems, n (%)

 - Diabetes

13 (10)

45 (20)

 

 - Heart

19 (15)

84 (37)

 

 - Stroke

6 (5)

32 (14)

 

 - Blood vessels or circulation

19 (15)

66 (29)

 

 - Lung or breathing

17 (13)

64 (28)

 

 - Liver

7 (5)

16 (7)

 

 - Joints, bones or muscles

52 (41)

161 (72)

 

 - Mental health

14 (11)

37 (16)

 

Chronic kidney disease stage, n (%)

 - CKD G2

14 (11)

17 (8)

 

 - CKD G3a

87 (68)

123 (55)

 

 - CKD G3b

26 (20)

68 (30)

 

 - CKD G4

1 (1)

17 (8)

 

Laboratory Variables, mean (SE)

 - eGFR (mL/min/1.73m2)

50.9 (0.7)

45.8 (0.7)

< 0.001*

 - Haemoglobin (g/L)

137.4 (1.7)

132.2 (1.1)

0.01

 - Albumin (g/L)

41.4 (0.5)

39.2 (0.4)

< 0.001*

Frailty Components, n (%)

 - Weakness/slowness

12 (9)

179 (80)

 

 - Exhaustion

41 (32)

208 (92)

 

 - Low physical activity

32 (25)

172 (76)

 

Slow walking pace, n (%)

11 (9)

130 (58)

 

VO2 Peak mL/kg/min, mean (SE)

33.9 (6.0)

21.7 (9.1)

< 0.001*

Total symptoms, mean (SE)

6.9 (0.3)

9.2 (0.1)

< 0.001*

Total symptom score, mean (SE)

14.6 (0.7)

24.9 (0.6)

< 0.001*

SF-12 PCS, mean (SE)

51.8 (0.6)

36.4 (0.7)

< 0.001*

SF-12 MCS, mean (SE)

53.8 (0.7)

50.2 (0.7)

< 0.001*

  1. Data presented as mean (SE) or frequencies (%). *Remain statistically significant following Bonferroni correction. Estimated VO2 Peak, (peak oxygen uptake). SF-12, Short Form-12